Skip to content
Try Mental Wellness – Lifestyle
Author:
Sanofi Winthrop Industrie
Press Release: Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy
June 10, 2026
Press Release: Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector
June 8, 2026
Press Release: Sanofi launches 2026 global employee stock purchase plan
June 4, 2026
Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease
May 28, 2026
←
Previous Page
1
2
3